Patent: 9,506,920
✉ Email this page to a colleague
Summary for Patent: 9,506,920
Title: | Assays for the detection of anti-TNF drugs and autoantibodies |
Abstract: | The present invention provides assays for detecting and measuring the presence or level of anti-TNF.alpha. drug therapeutics and autoantibodies in a sample. The present invention is useful for optimizing therapy and monitoring patients receiving anti-TNF.alpha. drug therapeutics to detect the presence or level of autoantibodies (e.g., HACA and/or HAHA) against the drug. |
Inventor(s): | Singh; Sharat (Rancho Santa Fe, CA), Wang; Shui Long (San Diego, CA), Ohrmund; Linda (San Diego, CA) |
Assignee: | Nestec S.A. (Vevey, CH) |
Application Number: | 14/336,955 |
Patent Claims: | see list of patent claims |
Details for Patent 9,506,920
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2029-10-26 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2029-10-26 |
Hoffmann-la Roche Inc. | ZENAPAX | daclizumab | Injection | 103749 | 12/10/1997 | ⤷ Try a Trial | 2029-10-26 |
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 11/23/2004 | ⤷ Try a Trial | 2029-10-26 |
Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 09/25/2009 | ⤷ Try a Trial | 2029-10-26 |
Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 12/30/2009 | ⤷ Try a Trial | 2029-10-26 |
Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | 01/08/2010 | ⤷ Try a Trial | 2029-10-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |